Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) have been given an average rating of "Buy" by the six brokerages that are currently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is C$12.67.
Separately, Canaccord Genuity Group set a C$15.00 price target on shares of Vitalhub and gave the company a "buy" rating in a report on Friday, August 28th.
View Our Latest Stock Report on VHI
Vitalhub Price Performance
Shares of VHI opened at C$7.37 on Wednesday. The stock has a market capitalization of C$466.23 million, a PE ratio of 61.42, a price-to-earnings-growth ratio of 1.18 and a beta of 1.40. The business's fifty day moving average price is C$7.66 and its 200 day moving average price is C$7.65. Vitalhub has a 12-month low of C$6.46 and a 12-month high of C$11.80.
Vitalhub (TSE:VHI - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. The firm had revenue of C$31.74 million during the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. As a group, research analysts anticipate that Vitalhub will post 0.23 earnings per share for the current fiscal year.
Vitalhub Company Profile
(
Get Free Report)
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.